Joint Full-Duplex/Half-Duplex Transmission-Switching Scheduling and Transmission-Energy Allocation in Cognitive Radio Networks with Energy Harvesting.

The full-duplex transmission protocol has been widely investigated in the literature in order to improve radio spectrum usage efficiency. Unfortunately, due to the effect of imperfect self-interference suppression, the change in transmission power and path loss of non-line-of-sight fading channels will strongly affect performance of full-duplex transmission mode. This entails that the full-duplex transmission protocol is not always a better selection compared to the traditional half-duplex transmission protocol.

Energy-Efficient Channel Handoff for Sensor Network-Assisted Cognitive Radio Network.

The visiting and less-privileged status of the secondary users (SUs) in a cognitive radio network obligates them to release the occupied channel instantly when it is reclaimed by the primary user. The SU has a choice to make: either wait for the channel to become free, thus conserving energy at the expense of delayed transmission and delivery, or find and switch to a vacant channel, thereby avoiding delay in transmission at the expense of increased energy consumption. An energy-efficient decision that considers the tradeoff between energy consumption and continuous transmission needs to be taken as to whether to switch the channels.

Goodness-of-fit based secure cooperative spectrum sensing for cognitive radio network.

Cognitive radio (CR) is a promising technology for improving usage of frequency band. Cognitive radio users (CUs) are allowed to use the bands without interference in operation of licensed users. Reliable sensing information about status of licensed band is a prerequirement for CR network.

Optimal throughput for cognitive radio with energy harvesting in fading wireless channel.

Energy resource management is a crucial problem of a device with a finite capacity battery. In this paper, cognitive radio is considered to be a device with an energy harvester that can harvest energy from a non-RF energy resource while performing other actions of cognitive radio. Harvested energy will be stored in a finite capacity battery.

Influence of daunorubicin and cytarabine sequencing on the outcome of therapy in acute myelogenous leukemia: a randomized trial.

Ninety-seven patients less than or equal to 70 years of age with previously untreated primary acute myeloblastic leukemia were randomly treated with either the DAT or TAD regimen: daunorubicin (70 mg/m2/day) administered on Days 1-3 (DAT) or 5-7 (TAD) of a 7-day sequence consisting of cytarabine (200 mg/m2/day) and 6-thioguanine (200 mg/m2/day). Complete responders received consolidation, maintenance, and final intensification over 14 months using mostly the same drugs as during induction and administered in the same sequence. The regimens did not significantly differ from each other with regard to toxicity or efficacy.

[Severe quantitative bone marrow insufficiency: results of treatment with high-dose antilymphocyte serum].

Nineteen patients with severe aplastic anaemia were treated with 21 courses of horse antithymocyte globulins (ATG). Changes in haematological parameters were correlated with ATG dosage. One of the 11 patients who received less than 100 mg/kg is still alive after more than 12 months.

[Highly malignant non-Hodgkin's lymphoma. Treatment by intensive sequential chemotherapy].

Sixty-two patients with aggressive non-Hodgkin's lymphoma (diffuse mixed, diffuse large cells, non-cleaved small cells (Burkitt-like), immunoblastic, lymphoblastic and other non-epidermotropic T lymphomas) were treated by intensive sequential chemotherapy combining heavy induction treatment (modified CHOP-Bleo), sequential consolidation treatment (cytosine arabinoside and thioguanine, then high-dose methotrexate and L-asparaginase) and final reinforcement (CVAP-Bleo). Complete remission was achieved in 59 patients (95%); 11 patients (18%) relapsed. Two patients died during the induction phase and one failed to respond.

Dysmyelopoietic syndromes. A search for prognostic factors in 193 patients.

Dysmyelopoietic syndromes cover sideroblastic or nonsideroblastic refractory anemia with or without excess of blasts, subacute or chronic myelomonocytic leukemia. The evolution of 193 patients was studied with regard to the initial hematologic picture. A certain number of variables of prognostic value have then been isolated: excess of marrow blasts (more than 5%); presence of circulating blasts or karyotypic anomalies; reduction in the number of polymorphonuclear leukocytes (less than 1.

[An empirical combination of antibiotics used in aplasias during chemotherapy for acute malignant hemopathies (author's transl)].

Continuous infusion of amikacin, cotrimoxazole and carbenicillin was the second empirically established combination of antibiotics used when fever occurred during the induction phase of chemotherapy in sixty-five patients (58 acute myeloid leukemias, 5 acute lymphoid leukemias, 2 non Hodgkin lymphomas). Clinical evidence of infection was available in 25 cases and the infection was bacteriologically documented in 19 cases. Therapy was successful in 57 patients (89%).

BCG therapy in acute non lymphoid leukaemias.

The survival of patients with acute non-lymphoid leukaemias (ANLL) receiving chemotherapy (32 patients) or chemotherapy plus BCG (31 patients) has been compared in a randomized trial which started in Nov 1974. Fresh BCG (Institut Pasteur, Paris) was administered by Heaf gun in the interval of chemotherapy cycles. The overall survival was better in the chemo-immunotherapy group (median duration of survival of 25 months compared to 16 months in the chemotherapy group).